Amid six years of near-zero interest rates, income-hungry investors have increasingly turned to dividend-paying stocks.
Companies have taken note by sweetening distributions. This year is on track to set a milestone for total dividend payouts.
Forty dividend stocks boosted payouts last week, including Bristol-Myers Squibb (NYSE: BMY) and General Electric (NYSE: GE).
Following are 25 notable hikes from the week ending Dec. 12.
Amid six years of near-zero interest rates, income-hungry investors have increasingly turned to dividend-paying stocks.
Companies have taken note by sweetening distributions. This year is on track to set a milestone for total dividend payouts.
Forty dividend stocks boosted payouts last week, including Bristol-Myers Squibb (NYSE: BMY) and General Electric (NYSE: GE).
Following are 25 notable hikes from the week ending Dec. 12.
One of the reasons biotech stocks can be your portfolio’s biggest winners is because of the massive profits companies see after releasing a blockbuster drug – especially with the exorbitantly high prices of this year’s new treatments.
Here are a closer look at the priciest drugs – and the biotech stocks behind them…
